Finance

Beta
Ask
Lists
7741:TYO
Hoya Corp
Â¥27,620.00
+2.05%
(+555.00) 1D
Jun 17, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 7741...
Open
Â¥27,025
High
Â¥27,685
Low
Â¥26,900
Mkt. cap
9.25T
Avg. vol.
1.09M
Volume
833.20K
Dividend
1.07%
Quarterly dividend
Â¥74
Ex-dividend date
Sep 29, 2025
P/E ratio
37.13
52-wk high
Â¥30,400
52-wk low
Â¥16,375
EPS
Â¥744
Shares outstanding
379.70M
No. of employees
38K
Open
Â¥27,025
High
Â¥27,685
Low
Â¥26,900
Mkt. cap
9.25T
Avg. vol.
1.09M
Volume
833.20K
Dividend
1.07%
Quarterly dividend
Â¥74
Ex-dividend date
Sep 29, 2025
P/E ratio
37.13
52-wk high
Â¥30,400
52-wk low
Â¥16,375
EPS
Â¥744
Shares outstanding
379.70M
No. of employees
38K
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to 7741 in the past 3 months
Strong Buy
Buy
9
Hold
1
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for 7741 in the last 3 months.
Highest
Current ¥27,620.00
Â¥35,033.67 (+26.84%)
Average
Â¥31,720.38 (+14.85%)
Lowest
Â¥29,027.90 (+5.10%)
News stories
From sources across the web
Profile
Hoya Corporation is a Japanese company manufacturing optical products such as photomasks, photomask blanks and hard disk drive platters, contact lenses and eyeglass lenses for the healthcare market, medical photonics, lasers, photographic filters, medical flexible endoscopy equipment, and software. Hoya Corporation is one of the Forbes Global 2000 Leading Companies and Industry Week 1000 Company. Wikipedia
About Hoya Corp
CEOEiichiro Ikeda
Employees37.8K
FoundedNov 1, 1941
HeadquartersShinjuku City, Tokyo, Japan
SectorMedical device
Websitehoya.com
Last report
Apr 30, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
248.13B / 241.57B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
220.88B
234.02B
244.72B
248.13B
Cost of goods sold
31.83B
172.07B
109.14B
113.70B
Cost of revenue
31.83B
172.07B
109.14B
113.70B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
70.68B
-35.23B
18.81B
19.29B
Operating expense
83.33B
32.69B
30.98B
66.76B
Total operating expenses
115.16B
204.76B
140.12B
180.46B
Operating income
105.72B
29.26B
104.60B
67.67B
Other non operating income
-39.35B
39.35B
-3.00M
211.00M
EBT including unusual items
67.36B
71.93B
110.80B
77.57B
EBT excluding unusual items
69.27B
72.11B
111.31B
72.72B
Income tax expense
15.96B
16.97B
19.62B
23.66B
Effective tax rate
23.70%
23.59%
17.71%
30.50%
Other operating expenses
-
80.56B
12.17B
47.46B
Net income
51.84B
55.43B
91.60B
54.22B
Net profit margin
23.47%
23.69%
37.43%
21.85%
Earnings per share
-
-
-
-
Interest and investment income
3.56B
3.34B
3.29B
3.12B
Interest expense
-488.00M
-500.00M
-497.00M
-506.00M
Net interest expenses
3.07B
2.84B
2.79B
2.62B
Depreciation and amortization charges
12.64B
-12.64B
-
-
EBITDA
118.36B
43.24B
119.73B
84.13B
Gain or loss from assets sale
484.00M
1.74B
423.00M
2.50B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer